Azenta, Inc.

AZTA Healthcare Medical Instruments & Supplies

Azenta, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $593.8 million, up 3.55% from fiscal 2024.

Revenue
+12.0%
EPS
+104.4%
Free cash flow
−134.7%

Quarter to June 2026, against a year earlier

39.23 1.85 +4.95%
Market cap
$1.6B
P/E
0.0×
Fwd P/E
−10.9×
Dividend yield
—
F-score
7/9
Altman Z
3.85
Beneish M
−2.63
Dividend safety
n/a

Azenta, Inc. (AZTA) P/E ratio

Alert me on P/E ratio

Azenta, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 107× (July 2015) — the current reading is the lowest in ten years.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 1.5× (97.80%)
FY2021 68.7× 30.67%
FY2020 52.6× 760.28%
FY2019 6.1× (70.75%)
FY2018 20.9× (39.78%)
FY2017 34.7× —
FY2016 0.0× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
Sep 2025 0.0× —
42 more quarters

Against its own ten years

Low 0.0× High 107×
Ten-year median 6.5×
Current reading's percentile 39

P/E ratio against peers

Company P/E ratio
PLSE Pulse Biosciences, Inc compare n/m
KMTS Kestra Medical Technologies, Ltd. compare n/m
STAA STAAR Surgical Company compare n/m
AZTA Azenta, Inc. n/m
XRAY DENTSPLY SIRONA Inc. compare n/m
STVN Stevanato Group S.p.A. compare 22.4×
LMAT LeMaitre Vascular, Inc. compare 29.7×
ATRC AtriCure, Inc. compare 199×
WRBY Warby Parker Inc. compare 434×
Medical Instruments & Supplies industry median 30.3×
Healthcare sector median 25.2×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on AZTA